Peggy Lillis Foundation

Our inaugural “Scientific Symposium,” debuting on Friday, November 15th, 2024. This virtual event will allow clinicians, scientists, nurses, pharmacists, and industry to intermingle and update each other during C. diff Awareness Month. The Symposium will also feature testimonials from C. diff patients and survivors.

 

Inaugural Scientific Symposium
13:50

Peggy Lillis Foundation

C. difficile Infection Epidemiology: Defining the Problem

FEATURING Alice Guh
  • 4 views
  • November 24, 2024
14:20

Peggy Lillis Foundation

Living with the Worry of the Next C.diff Episode - Results from a Consumer Survey

FEATURING Sandra Wingaard Thrane
  • 1 view
  • November 24, 2024
17:20

Peggy Lillis Foundation

Diagnosis of C. difficile Infection

FEATURING Erik Dubberke
  • 5 views
  • November 24, 2024
12:45

Peggy Lillis Foundation

Novel Small Molecule Treatment for C. difficile Infection, REC-3964

FEATURING Andrew Skinner
  • 1 view
  • November 24, 2024
13:50

Peggy Lillis Foundation

Pathophysiology of C. difficile

FEATURING Bruce Hirsch
  • 3 views
  • November 24, 2024
09:15

Peggy Lillis Foundation

Risk Factors for C. difficile Infection

FEATURING Vincent Young
  • 1 view
  • November 24, 2024
13:30

Peggy Lillis Foundation

Pediatric C. difficile Infection

FEATURING Maribeth Nicholson
  • 140 views
  • November 24, 2024
  • 2
10:47

Peggy Lillis Foundation

C. difficile Infection Control

FEATURING Cindy Hou
  • 1 view
  • November 24, 2024
07:09

Peggy Lillis Foundation

IDSA/SHEA Guidelines for Antimicrobial Managment of C. difficile Infection

FEATURING Stuart Johnson
  • 114 views
  • November 24, 2024
14:03

Peggy Lillis Foundation

Management of C. difficile Infections: GI Society Guidelines

FEATURING Colleen Kelly
  • 1 view
  • November 24, 2024
12:48

Peggy Lillis Foundation

Panel Discussion: The IDSA Vs. ACG Guidelines for Antimicrobial Management of CDI

FEATURING Paul Feuerstadt
  • 2 views
  • November 24, 2024
19:06

Peggy Lillis Foundation

Introduction to the Microbiota; FMT vs. LBP

FEATURING Glenn S Tillotson
  • 1 view
  • November 24, 2024
12:46

Peggy Lillis Foundation

Fecal Microbiota, Live-JSLM

FEATURING Sahil Khanna
  • November 24, 2024
06:03

Peggy Lillis Foundation

Repreve: A Pivotal Trial of Lumen Bio's New Low-Cost, Convenient C. difficile Preventative

FEATURING Carl Mason
  • November 24, 2024
11:21

Peggy Lillis Foundation

Ibezapolstat Preserves Key Clostridium Leptum Species. Microbiome Results from the Phase 2, Randomized, Double-Blind Study

FEATURING Kevin Garey
  • November 24, 2024
14:19

Peggy Lillis Foundation

Fecal Microbiota Spores, Live-BRPK

FEATURING Jessica Allegretti
  • 1 view
  • November 24, 2024
05:33

Peggy Lillis Foundation

VOS (fecal microbiota spores, live-brpk) Manufacturing: From donor-derived microbiota to Firmicutes capsules

FEATURING Jason Goldsmith
  • November 24, 2024
13:08

Peggy Lillis Foundation

Enzyme Immunoassay (EIA) CDI Diagnostic Testing

FEATURING Stuart Cohen
  • 6 views
  • November 24, 2024
11:43

Peggy Lillis Foundation

Clinical Development Of AZD5148: A Monoclonal Antibody Against Toxin B for the Reduction of CDI Recurrence

FEATURING Ann Marie Stanley
  • November 24, 2024
13:09

Peggy Lillis Foundation

Vedanta's Clinical Trials to Prevent Recurrent C. diff Infections: Transforming the Field with First Live Biotherapeutic Products

FEATURING Steven Shiff
  • November 24, 2024
18:15

Peggy Lillis Foundation

CRS3123: A Narrow Spectrum Agent for Treatment of CDI

FEATURING Jon Bruss
  • November 24, 2024
12:46

Peggy Lillis Foundation

ProbioTech USA Biosciences: The Next Generation of Rx LBP, Present and Future

FEATURING Sahil Khanna
  • November 24, 2024